AgingResearch.NewsJoin free

N-3 fatty acids

N-3 fatty acids has been studied in 1 paper since 2016: 1 trial in people. The newest paper, Mar 19, 2016: “n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease”.

Intervention

1 paper studies it1 findingUpdated

“There was no effect of n-3 fatty acids or CoQ on neutrophil or PBMC telomere length.”
n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney DiseaseNutrients2016doi:10.3390/nu8030175

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab in 1 country
  • Funders: Medical Research Council and 1 more
  • Human trial1

What did studies of N-3 fatty acids find?

1

Studies of N-3 fatty acids measured 1 outcome; the most studied are neutrophil and PBMC telomere length (1 study).

Neutrophil and PBMC telomere length

no changein humans1

1 study

  1. N-3 fatty acids have no effect on neutrophil and PBMC telomere length in humans.

    “There was no effect of n-3 fatty acids or CoQ on neutrophil or PBMC telomere length.”

    Human trialchronic kidney diseaseneutrophils and peripheral blood mononuclear cells4 g daily8 weeksn = 85

    n-3 Fatty Acid Supplementation and Leukocyte Telomere Length in Patients with Chronic Kidney Disease

    Nutrients

More on Neutrophil and PBMC telomere length

Latest

Related